GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Firefly Neuroscience Inc
Firefly, a company developing technologies for diagnosing and treating mental disorders, is a bet on innovation in this complex field. Its price is volatile and dependent on research results and regulatory approvals.
Share prices of companies in the market segment - Neuro
Firefly Neuroscience uses EEG analysis and artificial intelligence to objectively assess and diagnose mental disorders. We've categorized it under "Neurology." The chart below shows how investors value companies bringing data-driven approaches to psychiatry.
Broad Market Index - GURU.Markets
Firefly Neuroscience uses EEG analysis and artificial intelligence to objectively assess and diagnose mental disorders. As part of the GURU.Markets index, it brings data-driven approaches to psychiatry. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
AIFF - Daily change in the company's share price Firefly Neuroscience Inc
Firefly Neuroscience, Inc.'s daily share price fluctuations reflect the high volatility inherent in biotech companies. This metric measures the company's sensitivity to news about the development of its platform for diagnosing mental disorders.
Daily change in the price of a set of shares in a market segment - Neuro
Firefly Neuroscience, Inc. is a biotech company. This chart shows the extreme volatility of the sector. Comparison with AIFF, which focuses on mental health diagnostics, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Firefly Neuroscience uses EEG and AI data to aid in the diagnosis and treatment of mental disorders. It's a cutting-edge biotech company, and its stock is driven by research news. Its high volatility reflects the high risks and promises of treating mental illnesses.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Firefly Neuroscience Inc
Firefly Neuroscience, Inc.'s year-over-year performance is a story about the adoption of its platform for objectively assessing mental disorders. Its 12-month market cap depends on progress toward FDA approval and convincing physicians of the value of its EEG-based technology, which promises to revolutionize the diagnosis of depression and other conditions.
Annual dynamics of market capitalization of the market segment - Neuro
Firefly, a private company, is developing technology for the objective diagnosis of neurological disorders. Its growth depends on approval and acceptance by physicians. Its valuation will reflect its disruptive potential for traditional psychiatry, outpacing the sector if successful.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Firefly Neuroscience is a medical technology company. Its stock price performance since its IPO is a speculative bet on its ability to commercialize its platform for diagnosing mental disorders. The chart reflects not economic cycles, but rather investors' faith in the future of neurotechnology.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Firefly Neuroscience Inc
Firefly Neuroscience is developing a platform for diagnosing and treating mental disorders. Being in the development stage, its monthly pricing is dependent on news releases. Progress in clinical trials and interactions with the FDA are the main events shaping its schedule.
Monthly dynamics of market capitalization of the market segment - Neuro
Firefly Neuroscience uses EEG and AI to diagnose and treat mental and neurological disorders. This "Neurotech" sector is at the intersection of medicine and high technology. The chart below shows how investors assessed the prospects for objectifying psychiatry through data analysis and their belief in the rapid commercialization of such approaches.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Firefly Neuroscience uses AI to analyze EEGs, aiding in the diagnosis of mental disorders. This company is at the intersection of medicine, AI, and neuroscience. Its stock price depends on the acceptance of its technology by doctors and regulatory approval. It is betting on a technological revolution in psychiatry.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Firefly Neuroscience Inc
Firefly Neuroscience develops EEG-based diagnostic tools for assessing cognitive disorders. Its weekly stock price is highly volatile, depending on news of FDA approval and the pace of clinical adoption of its technology, which is key for medical startups.
Weekly dynamics of market capitalization of the market segment - Neuro
Firefly Neuroscience develops EEG-based diagnostic tools for assessing cognitive disorders. Its weekly stock price is highly volatile, depending on news of FDA approval and the pace of clinical adoption of its technology, which is key for medical startups.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Firefly, a medical technology company, lives in a world of its own. Its performance is driven by news of regulatory approvals. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall on company-specific events, completely ignoring the market.
Market capitalization of the company, segment and market as a whole
AIFF - Market capitalization of the company Firefly Neuroscience Inc
Firefly Neuroscience's market cap is a story about the application of EEG and AI to objectively diagnose and treat mental disorders. The company's stock price reflects investors' belief that its technology can revolutionize psychiatry. Its speculative performance is a bet that brain data will be key to understanding and treating depression.
AIFF - Share of the company's market capitalization Firefly Neuroscience Inc within the market segment - Neuro
Firefly Neuroscience uses electroencephalography (EEG) and AI to aid in the diagnosis and treatment of mental disorders. Its market capitalization reflects the potential of its innovative approach. The chart below shows how investors assess its chances of widespread clinical adoption.
Market capitalization of the market segment - Neuro
Firefly Neuroscience has developed an EEG-based platform for objective assessment and treatment of mental disorders. The chart below shows the overall market capitalization of the neuroscience sector. It illustrates an attempt to bring objective data to psychiatry, which traditionally relies on subjective assessments.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph shows objective diagnostics for psychiatry. Firefly Neuroscience has developed an EEG-based platform to aid in the diagnosis and treatment of mental disorders. Its strategy is a bet that brain data will help make psychiatry a more precise science.
Book value capitalization of the company, segment and market as a whole
AIFF - Book value capitalization of the company Firefly Neuroscience Inc
Firefly Neuroscience's foundation is its EEG- and AI-based platform for objective assessment and treatment of neuropsychiatric disorders. Its book value reflects this advanced diagnostic capital. The chart below will show how the company is accumulating resources to commercialize its innovative approach to mental health.
AIFF - Share of the company's book capitalization Firefly Neuroscience Inc within the market segment - Neuro
Firefly Neuroscience is a company developing an EEG-based platform for the diagnosis and treatment of mental disorders. Its assets include R&D centers and equipment. The chart shows the company's share of this new physical infrastructure for objectively assessing brain health.
Market segment balance sheet capitalization - Neuro
Neurotechnology, as the BCap_Ges chart for biotech shows, is knowledge-intensive. Firefly Neuroscience, which develops diagnostic tools for mental disorders, invests in R&D and data rather than building factories.
Book value of all companies included in the broad market index - GURU.Markets
Firefly Neuroscience's assets include capital and a platform for AI-powered EEG analysis. Its book value reflects the financial and IT foundation for creating a tool that can objectively measure brain activity, aiding in the diagnosis and treatment of real mental disorders.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Firefly Neuroscience Inc
Firefly Neuroscience uses EEG and AI to diagnose mental disorders. It's a MedTech company whose value lies in its unique approach and database. Its book value is low. Its market capitalization is a bet on its technology's ability to objectify and improve psychiatric diagnostics, a huge need.
Market to book capitalization ratio in a market segment - Neuro
Firefly Neuroscience uses EEG and artificial intelligence to diagnose mental disorders. Its value lies in its unique technology platform. The chart shows how the market is valuing its innovative approach to objectively assessing brain health.
Market to book capitalization ratio for the market as a whole
Firefly Neuroscience uses EEG and AI to aid in the diagnosis and treatment of mental and neurological disorders. It is a MedTech company whose value lies in its unique data and algorithms. The chart shows how the market is evaluating innovative approaches to objectively assessing brain health, which have the potential to transform psychiatry.
Debts of the company, segment and market as a whole
AIFF - Company debts Firefly Neuroscience Inc
Firefly Neuroscience, a company developing a platform for diagnosing and treating neurological disorders, uses capital for clinical validation and commercialization. Translating scientific data into an approved medical tool is an expensive process. This chart shows how the company is funding its path to changing approaches in psychiatry and neurology.
Market segment debts - Neuro
Firefly Neuroscience uses EEG and AI to diagnose and treat mental and neurological disorders. Medtech companies that combine hardware and software require investment in both areas. This chart shows how Firefly funds its innovative research at the intersection of neuroscience and artificial intelligence.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Firefly Neuroscience Inc
Firefly Neuroscience develops technologies for the diagnosis and treatment of neurological disorders. This chart illustrates the company's reliance on external funding for its innovative, yet expensive, research. High debt can accelerate development, but it creates pressure to quickly secure regulatory approval and market entry.
Market segment debt to market segment book capitalization - Neuro
Firefly Neuroscience uses EEG and artificial intelligence to objectively assess and treat mental disorders. This chart reflects debt trends in the medtech sector, helping to understand how the company is funding its innovative research at the intersection of neuroscience and software, aiming to transform approaches to psychiatric diagnosis.
Debt to book value of all companies in the market
Firefly Neuroscience uses EEG and artificial intelligence to objectively assess and treat neurological and psychiatric disorders. For a company operating at the intersection of medicine and high technology, the overall investment climate, reflected in this graph, is critically important. It determines the availability of funding for R&D and the commercialization of new technologies.
P/E of the company, segment and market as a whole
P/E - Firefly Neuroscience Inc
This chart of Firefly Neuroscience, a company developing diagnostic tools for neurology, shows the market valuation of its innovative technology. The dynamics reflect investors' belief that objectively measuring brain activity will aid in the diagnosis and treatment of mental disorders, creating a new standard.
P/E of the market segment - Neuro
This chart shows the average price-to-earnings ratio for the medical technology sector, where Firefly Neuroscience develops diagnostics. The industry's high valuation reflects a belief in innovation. This metric helps understand the market premium placed on Firefly's platform for diagnosing mental disorders.
P/E of the market as a whole
Firefly Neuroscience uses electroencephalogram (EEG) data and artificial intelligence to aid in the diagnosis and treatment of mental disorders. This is a new approach in psychiatry. This chart shows sentiment in the medtech sector. It helps understand whether the market believes objective EEG data can revolutionize mental health diagnosis and the potential of the Firefly platform.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Firefly Neuroscience Inc
Firefly Neuroscience uses EEG data and artificial intelligence to aid in the diagnosis and treatment of mental and neurological disorders. This is at the forefront of medical technology. This graph reflects analysts' expectations regarding whether the company will be able to commercialize its technology and convince doctors to use it in clinical practice.
%20P%2FE%20Firefly%20Neuroscience%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Firefly-Neuroscience-Inc&v=1772629017755 "Chart of the company's future (projected) P/E Firefly Neuroscience Inc")
Future (projected) P/E of the market segment - Neuro
Using EEG data and artificial intelligence, Firefly Neuroscience has developed a platform for objective assessment and treatment of mental disorders. This chart shows how its future revenue expectations compare to the industry average. Does the market believe it can bring objectivity to psychiatry?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Neuro&v=1772629017778 "Future (projected) P/E graph of the market segment - Neuro")
Future (projected) P/E of the market as a whole
Firefly Neuroscience uses EEG and AI to aid in the diagnosis and treatment of mental disorders. It's a breakthrough technology at the intersection of medicine and IT. This market valuation chart shows how much investors are willing to pay for innovation. During periods of optimism, companies like Firefly that are transforming healthcare attract increased attention.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772629017813 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Firefly Neuroscience Inc
Firefly Neuroscience, Inc. uses EEG and AI to objectively assess and assist in the diagnosis of mental disorders. The company's profitability depends on the implementation of its technology in clinical practice. This graph shows the path from scientific development to commercialization of a tool that could change approaches to diagnosis and treatment in psychiatry.
Profit of companies in the market segment - Neuro
Firefly Neuroscience uses EEG and artificial intelligence to objectively assess and diagnose mental disorders such as depression. Its technology aims to replace subjective questionnaires. This graph illustrates the potential in the neurotechnology sector, where the use of AI to analyze biosignals could revolutionize psychiatry and neurology.
Overall market profit
Firefly Neuroscience develops technologies for objective mental health assessment, such as EEG analysis. The adoption of such innovations in clinical practice depends on the willingness of the medical community and insurers to embrace them. Economic growth, reflected in the graph, is driving investment in new medical technologies.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Firefly Neuroscience Inc
Firefly Neuroscience is developing a platform based on EEG and artificial intelligence for the objective assessment and diagnosis of mental disorders. This has the potential to revolutionize psychiatry. This chart represents a consolidated analyst forecast, which is a bet on the commercialization of this innovative diagnostic technology.
%20profit%20of%20the%20company%20Firefly%20Neuroscience%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Firefly-Neuroscience-Inc&v=1772629017904 "Graph of future (projected) profit of the company Firefly Neuroscience Inc")
Future (predicted) profit of companies in the market segment - Neuro
Firefly Neuroscience uses electroencephalogram (EEG) data and artificial intelligence to aid in the diagnosis and treatment of mental and neurological disorders. The company's platform provides physicians with objective data for decision-making. This chart shows profitability forecasts for the medical devices and biotechnology sectors, highlighting the potential of AI in psychiatry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Neuro&v=1772629017946 "Graph of future (predicted) profits of companies in a market segment - Neuro")
Future (predicted) profit of the market as a whole
Firefly Neuroscience develops tools for objectively assessing cognitive function, particularly based on EEG. Demand for its technology depends on the budgets of medical and research institutions. This schedule, reflecting profitability expectations, indirectly influences the funding available for the implementation of new diagnostic technologies in healthcare.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772629017973 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Firefly Neuroscience Inc
Firefly Neuroscience develops technologies for the diagnosis and treatment of neurological disorders. This chart shows the market valuation of its innovations. The high valuation relative to revenue reflects the company's hope that its technologies will lead to breakthroughs in the understanding and treatment of brain diseases.
P/S market segment - Neuro
Firefly Neuroscience, Inc. is developing an EEG- and AI-based platform for the objective assessment and treatment of mental disorders. This chart shows the average revenue estimate for the medical technology sector. It helps understand how the market perceives the potential of Firefly's technology to revolutionize the diagnosis and treatment of conditions such as depression and ADHD.
P/S of the market as a whole
Firefly Neuroscience is developing a platform based on EEG and artificial intelligence for the objective assessment and treatment of mental disorders such as depression. Their goal is to bring precision to psychiatry. This chart provides a general revenue metric against which to judge how highly investors value the use of AI in diagnosing brain disorders.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Firefly Neuroscience Inc
Firefly Neuroscience uses EEG and artificial intelligence to objectively assess and diagnose mental disorders. This chart reflects market expectations for the implementation of its technology in clinical practice. This estimate is based on future revenue from its platform, which has the potential to revolutionize psychiatric diagnosis and treatment.
%20P%2FS%20Firefly%20Neuroscience%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Firefly-Neuroscience-Inc&v=1772629018034 "The graph of the company's future (projected) P/S Firefly Neuroscience Inc")
Future (projected) P/S of the market segment - Neuro
Firefly Neuroscience is developing an EEG- and AI-based platform for the objective assessment and treatment of mental disorders such as depression. This is an innovative approach in psychiatry. This chart shows how the market values its diagnostic technology compared to the neuroscience and medical device sectors.
%20P%2FS%20market%20segment%20graph%20-%20Neuro&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Neuro&v=1772629018046 "Future (projected) P/S market segment graph - Neuro")
Future (projected) P/S of the market as a whole
Firefly Neuroscience is developing EEG-based technology for the objective assessment and treatment of neurological and psychiatric disorders. This graph, reflecting the market's willingness to invest in breakthrough medical technologies, is important to Firefly. Market optimism is helping to attract the funding needed to bring innovative diagnostic tools to market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772629018090 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Firefly Neuroscience Inc
Firefly Neuroscience is developing an EEG- and AI-based platform for the objective assessment and treatment of neuropsychiatric disorders. This graph reflects revenue, which could come from device sales, software subscriptions, or partnerships with pharmaceutical companies. It demonstrates the commercialization of this innovative approach to mental health.
Sales of companies in the market segment - Neuro
Firefly Neuroscience, Inc. is a medical technology company that uses artificial intelligence to analyze EEGs and assist in the diagnosis and treatment of mental disorders. The company's business can be divided into hardware sales and subscriptions to its analytics platform. This chart shows revenue from one of these segments in the neurotechnology field.
Overall market sales
Firefly Neuroscience, Inc. uses EEG data and artificial intelligence to objectively assess and treat neurological and psychiatric disorders. This innovative approach has the potential to revolutionize psychiatry by making diagnostics more accurate. The company is at the intersection of medicine and AI, creating a new market for digital diagnostics in healthcare.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Firefly Neuroscience Inc
Firefly Neuroscience uses EEG and artificial intelligence to objectively assess cognitive function in disorders such as depression and ADHD. Its future sales forecast is based on expectations for the implementation of its technology in clinical practice to aid in diagnosis and treatment selection. This is a bet on the digitalization and objectification of psychiatry.
%20sales%20of%20the%20company%20Firefly%20Neuroscience%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Firefly-Neuroscience-Inc&v=1772629018162 "Schedule of future (projected) sales of the company Firefly Neuroscience Inc")
Future (projected) sales of companies in the market segment - Neuro
Firefly Neuroscience uses EEG and artificial intelligence to aid in the diagnosis and treatment of mental and neurological disorders. This graph reflects expectations for the entire neuroscience sector. It helps understand the demand for objective diagnostic methods in psychiatry and the potential analysts predict for AI in medicine.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Neuro&v=1772629018179 "Schedule of future (projected) sales of companies in the market segment - Neuro")
Future (projected) sales of the market as a whole
Firefly Neuroscience develops diagnostic tools for assessing cognitive function. Demand for its products will depend on their adoption in clinical practice. This graph of overall sales forecasts reflects the economic climate, which impacts healthcare budgets and their willingness to purchase new equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772629018183 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Firefly Neuroscience Inc
Firefly Neuroscience, Inc. uses EEG and artificial intelligence to objectively assess and assist in the treatment of neurological and psychiatric disorders. This graph shows the company's path to commercialization, reflecting the balance between revenue from its diagnostic platform and ongoing R&D investments to expand its capabilities.
Market segment marginality - Neuro
Firefly Neuroscience uses EEG and AI to analyze brain activity to improve the diagnosis and treatment of mental and neurological disorders. Profitability in the AI-based healthcare industry depends on the accuracy of their platform. The graph shows how effective their data-intensive business model is compared to traditional diagnostic methods.
Market marginality as a whole
Firefly Neuroscience, Inc. is developing an EEG- and AI-based platform for the objective assessment and treatment of mental disorders. This could revolutionize psychiatry. This chart shows the profitability of existing businesses, while for AIFF, value is determined by the potential of its technology to bring objectivity to mental health diagnosis and treatment.
Employees in the company, segment and market as a whole
Number of employees in the company Firefly Neuroscience Inc
Firefly Neuroscience is developing an objective method for assessing and treating mental disorders using EEG. This graph shows the team of neuroscientists and engineers. The growth of this team reflects progress toward commercializing their innovative approach, which could bring greater precision to psychiatry.
Share of the company's employees Firefly Neuroscience Inc within the market segment - Neuro
Firefly Neuroscience uses EEG and AI to aid in the diagnosis and treatment of mental and neurological disorders. This innovative approach requires a team of neuroscientists and data scientists. This metric reflects its role as an employer at the intersection of neuroscience and artificial intelligence.
Number of employees in the market segment - Neuro
Firefly Neuroscience uses electroencephalography (EEG) and artificial intelligence to objectively assess cognitive function. This chart shows employment in the neuroscience sector. The growing number of neuroscientists and data scientists reflects advances in our understanding of brain function and the need for accurate tools for diagnosing mental and neurological disorders.
Number of employees in the market as a whole
Firefly Neuroscience uses EEG and AI to diagnose and treat mental disorders. The NeuroTech sector is growing as awareness of the importance of mental health increases. This chart shows the overall economy, but for Firefly, the driving force is technological advancement and the need for objective methods of assessing brain function.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Firefly Neuroscience Inc (AIFF)
Firefly Neuroscience, Inc. is developing an EEG-based platform for the objective assessment of mental disorders. MedTech companies with a strong IT component often have high market capitalization per employee. This chart reflects the market's appreciation for the potential of the unique technology and data generated by a small team.
%20of%20the%20company%20Firefly%20Neuroscience%20Inc%20(AIFF)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Firefly-Neuroscience-Inc-AIFF&v=1772629018308 "Chart of market capitalization per employee (in thousands of dollars) of the company Firefly Neuroscience Inc (AIFF)")
Market capitalization per employee (in thousands of dollars) in the market segment - Neuro
Firefly Neuroscience uses EEG and artificial intelligence to objectively assess and treat neurological and psychiatric disorders. For a company at the intersection of medicine and AI, this metric reflects the value of their technology platform and the data they collect. It's a measure of how the market values their innovative approach to brain health.
%20by%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Neuro&v=1772629018315 "Market capitalization per employee (in thousands of dollars) by market segment - Neuro")
Market capitalization per employee (in thousands of dollars) for the overall market
Firefly Neuroscience, Inc. (AIFF) has developed an EEG- and AI-based platform for objective assessment and treatment of mental disorders. This is a breakthrough in psychiatry, which has long relied on subjective assessments. The chart reflects the enormous potential the market sees in this innovative medical technology.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772629018357 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Firefly Neuroscience Inc (AIFF)
Firefly Neuroscience uses EEG and AI to analyze brain function to aid in the diagnosis and treatment of mental disorders. It's a digital health company. This graph is likely negative. It shows how much capital is being invested in each scientist and data analyst to commercialize this platform, turning brain scanning into a profitable diagnostic tool.
%20Chart%20Firefly%20Neuroscience%20Inc%20(AIFF)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Firefly-Neuroscience-Inc-AIFF&v=1772629018385 "Company Profit Per Employee (in thousands of dollars) Chart Firefly Neuroscience Inc (AIFF)")
Profit per employee (in thousands of dollars) in the market segment - Neuro
Firefly Neuroscience is developing an EEG- and AI-based platform for the objective assessment and treatment of mental disorders. In the data-driven MedTech sector, the work of a team of analysts and engineers is crucial. This graph shows how effectively they are monetizing their unique technology, allowing them to compare with other neurotechnology companies.
%20in%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Neuro&v=1772629018426 "Chart of profit per employee (in thousands of dollars) in the market segment - Neuro")
Profit per employee (in thousands of dollars) for the market as a whole
Firefly Neuroscience (AIFF) uses EEG and AI to diagnose and treat mental disorders. It's a MedTech company at the intersection of R&D and commercialization. This metric reflects how successfully their team (scientists and engineers) is promoting their platform to clinics, and how R&D costs compare to initial revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772629018429 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Firefly Neuroscience Inc (AIFF)
Firefly Neuroscience develops technologies for objective assessment of cognitive functions. This graph shows the company's path to monetization of its diagnostic platform. Increasing revenue per employee will indicate the adoption of its technology in clinical and research settings.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Firefly-Neuroscience-Inc-AIFF&v=1772629018459 "Sales chart per company employee Firefly Neuroscience Inc (AIFF)")
Sales per employee in the market segment - Neuro
Firefly Neuroscience uses EEG and AI to create objective metrics of brain health, aiding in the diagnosis and treatment of neurological and mental disorders. This chart compares Firefly's revenue per employee to the industry average, demonstrating the relevance of their EEG analysis AI platform to clinicians.
Sales per employee for the market as a whole
Firefly Neuroscience (AIFF) is a MedTech company that has developed a platform (based on EEG and AI) for the objective diagnosis and treatment of mental disorders. This R&D company is transitioning to the commercial stage. This chart shows how effectively their team is starting to sell this innovative diagnostic service to clinics.
Short shares by company, segment and market as a whole
Shares shorted by company Firefly Neuroscience Inc (AIFF)
Firefly Neuroscience (AIFF) uses EEG and AI to diagnose and treat neurological disorders (such as depression). This innovative approach requires approval not only from regulators but also from the conservative medical community. This chart shows the number of skeptics who question its scientific validity or commercial potential.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Firefly-Neuroscience-Inc-AIFF&v=1772629018610 "Short Shares Chart for the Company Firefly Neuroscience Inc (AIFF)")
Shares shorted by market segment - Neuro
Firefly Neuroscience (formerly EGI) uses EEG technology and AI to analyze brain activity to aid in the diagnosis of mental disorders such as depression. This chart shows the betting against the neurotech sector, reflecting investor skepticism that EEG data can become a reliable diagnostic tool for psychiatry.
Shares shorted by the overall market
Firefly (AIFF) is a clinical-stage biotech company. Its survival depends entirely on access to capital markets. When this market pessimism indicator rises, it signals a "venture winter." Investors panic and flee unprofitable biotechs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Firefly Neuroscience Inc (AIFF)
Firefly Neuroscience uses EEG and AI to analyze brain function, aiding in the diagnosis and treatment of mental disorders. It's a breakthrough technology in neuroscience. This indicator tracks investor hype, indicating "overheating" (above 70) on breakthrough news or "oversold" (below 30) pending FDA approval.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Firefly-Neuroscience-Inc-AIFF&v=1772629018697 "RSI 14 indicator chart for the company's stock Firefly Neuroscience Inc (AIFF)")
RSI 14 Market Segment - Neuro
Firefly Neuroscience uses EEG (electroencephalogram) and AI to analyze brain activity. Their platform helps doctors more objectively diagnose and treat mental disorders. This graph measures the collective excitement in the neuroscience biotech sector, helping determine whether the entire segment is overhyped.
RSI 14 for the overall market
For Firefly Neuroscience, a biotech company in R&D, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AIFF (Firefly Neuroscience Inc)
Firefly Neuroscience uses EEG (electroencephalogram) and AI to aid in the diagnosis and treatment of mental disorders such as depression. This chart shows the average target price. Analysts' forecasts are based on successful commercialization of this diagnostic platform and the acquisition of insurance coverage.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AIFF-Firefly-Neuroscience-Inc&v=1772629018819 "A chart showing analyst consensus forecasts for the expected stock price. AIFF (Firefly Neuroscience Inc)")
The difference between the consensus estimate and the actual stock price AIFF (Firefly Neuroscience Inc)
Firefly Neuroscience (AIFF) is a medical technology company that uses AI to analyze EEG (brainwave) data to help doctors objectively diagnose and treat depression. This chart shows how far the current stock price differs from the "fair" value predicted by analysts, reflecting their belief in this "precision psychiatry."
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AIFF-Firefly-Neuroscience-Inc&v=1772629018822 "A chart showing the difference between the consensus forecast and the actual stock price. AIFF (Firefly Neuroscience Inc)")
Analyst consensus forecast for stock prices by market segment - Neuro
Firefly Neuroscience is a medical company that uses AI-powered EEG (electroencephalogram) analysis to objectively diagnose mental disorders (depression, ADHD). This chart shows the general expectations of analysts across the neuroscience sector. It reflects whether experts believe in digital diagnosis of brain diseases.
Analysts' consensus forecast for the overall market share price
Firefly Neuroscience is a healthcare company that uses AI to analyze EEG (brainwaves) to help doctors objectively diagnose mental disorders like depression. This chart shows overall risk appetite. For Firefly, a company with breakthrough but not yet implemented technology, overall market optimism (risk appetite) is important for funding and market acceptance.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Firefly Neuroscience Inc
Firefly Neuroscience is EEG 2.0. They use AI to analyze EEG (brain electrical activity) data to objectively diagnose mental disorders (depression, ADHD) and help doctors tailor treatment. This graph summarizes their implementation history, reflecting their (slow) path to FDA approval and their efforts to digitize psychiatry.
AKIMA Market Segment Index - Neuro
Firefly Neuroscience (AIFF) is a medical technology company that uses EEG and AI to objectively assess cognitive function, aiding in the diagnosis of depression and other CNS disorders. The chart shows the average index for the segment, helping investors assess how this AI-based neuroscience diagnostic compares to the sector average.
The AKIM Index for the overall market
Firefly Neuroscience is a company that uses AI to analyze EEG data (Brain Network Analytics) for diagnostics and drug development. This chart, which reflects the market average, provides context. It helps assess how this neurotechnological story fits in with overall macroeconomic trends and interest in brain health.
